Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter-Reference-Cited by-同舟云学术

Outcomes of extra-cranial stereotactic body radiotherapy for metastatic colorectal cancer: Dose and site of metastases matter

Published:2020-01 Issue: Volume:142 Page:236-245
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Thompson Robert,Cheung Patrick,Chu William,Myrehaug Sten,Poon Ian,Sahgal Arjun,Soliman Hany,Tseng Chia-Lin,Wong Shun,Ung Yee,Beatriz Kinupe Abrahão Ana,Erler Darby,Zhang Liying,Ko Yoo-Joung,Chung Hans T.

Funder

Sunnybrook Odette Cancer Centre

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference26 articles.

1. Role of surgery in colorectal cancer liver metastases;Akgul;World J Gastroenterol,2014

2. Pulmonary metastasectomy for colorectal cancer: how many nodules, how many times?;Kim;World J Gastroenterol,2014

3. Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice;Timmerman;J Clin Oncol,2014

4. Radical irradiation of extracranial oligometastases;Salama;J Clin Oncol,2014

5. Stereotactic body radiotherapy for oligoprogressive cancer;Cheung;Br J Radiol,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic ablative radiotherapy for oligoprogressive solid tumours: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-11

2. Systematic review of the efficacy of stereotactic ablative radiotherapy for oligoprogressive disease in metastatic cancer;Radiotherapy and Oncology;2024-07

3. Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors;JAMA Oncology;2024-07-01

4. Clinical outcomes of multisite moderate to high dose radiotherapy for patients with metastatic melanoma;Precision Radiation Oncology;2024-03-24

5. Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma;Cancer Research and Treatment;2024-01-15